Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.23 USD
Change Today +0.12 / 1.32%
Volume 4.1M
ACHN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ACHILLION PHARMACEUTICALS (ACHN)

Achillion Pharmaceuticals, Inc. to Report Q4, 2012 on Feb 20, 2013
CapIQ 02/20/2013 10:00 PM ET
Achillion Pharmaceuticals, Inc. to Report Q2, 2012 on Aug 08, 2012
CapIQ 02/20/2013 10:00 PM ET
Achillion Pharmaceuticals, Inc. to Report Q4, 2011 on Mar 08, 2012
CapIQ 02/20/2013 10:00 PM ET

2013 revenues at Achillion Pharmaceuticals, Inc. totaled $0.0 USD, while annual losses equaled $0.63 per share.

Quarterly Earnings & Estimates - ACHILLION PHARMACEUTICALS (ACHN)

Actuals vs. Estimates for ACHILLION PHARMACEUTICALS ACHN

Achillion Pharmaceuticals, Inc.'s Quarterly Earnings

Achillion Pharmaceuticals, Inc. reported 1st quarter 2014 losses of $0.17 per share on 05/9/2014.

Annual Earnings & Estimates - ACHILLION PHARMACEUTICALS (ACHN)

Actuals vs. Estimates for ACHILLION PHARMACEUTICALS ACHN

Achillion Pharmaceuticals, Inc.'s Annual Earnings

Achillion Pharmaceuticals, Inc. reported annual 2013 losses of $0.63 per share on 03/9/2014.

Quarterly Revenues - ACHILLION PHARMACEUTICALS (ACHN)

Actuals vs. Estimates for ACHILLION PHARMACEUTICALS ACHN

Achillion Pharmaceuticals, Inc.'s Quarterly Revenues

Achillion Pharmaceuticals, Inc. did not report revenues for the 1st quarter 2014. However, during the 1st quarter of the prior year the company reported revenues of $0.0 USD.

Annual Revenues - ACHILLION PHARMACEUTICALS (ACHN)

Actuals vs. Estimates for ACHILLION PHARMACEUTICALS ACHN

Achillion Pharmaceuticals, Inc.'s Annual Revenues

Achillion Pharmaceuticals, Inc. did not report revenues for the full year 2013. However, during the prior year the company reported revenues of $2.6M USD.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACHN:US $9.23 USD +0.12

ACHN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,474 GBp +48.50
Bavarian Nordic A/S kr326.50 DKK -5.50
Bayer AG €137.75 EUR 0.00
Chimerix Inc $42.89 USD +0.65
Emergent Biosolutions Inc $30.80 USD -0.28
View Industry Companies
 

Industry Analysis

ACHN

Industry Average

Valuation ACHN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.